Common Reasons IRB Applications Get Rejected (And How to Avoid Them)
For researchers eager to begin their clinical studies, few things are more frustrating than an Institutional Review Board (IRB) rejection. Beyond the disappointment, rejections can delay research timelines by weeks or even months, impact funding deadlines, and strain relationships with study sponsors.
The good news? Most IRB rejections are entirely preventable. By understanding the common pitfalls that cause applications to be rejected and taking proactive steps to address them, researchers can significantly improve their chances of first-time approval.
Why IRB Applications Get Rejected
Before diving into specific reasons, it's important to understand that IRB rejections typically stem from two fundamental issues: incomplete information or concerns about participant safety and welfare. The IRB's primary responsibility is protecting research participants, so any application that raises red flags in these areas will face scrutiny or outright rejection.
Let's explore the most common reasons IRB applications get rejected and, more importantly, how to avoid them.
1. Inadequate Informed Consent Documents
The Problem
Informed consent is the cornerstone of ethical research, yet it's one of the most frequently cited reasons for IRB rejection. Common issues include:
- Using overly technical language that participants cannot understand
- Failing to adequately describe risks and benefits
- Omitting required elements such as compensation details or withdrawal procedures
- Including exculpatory language that waives participants' legal rights
- Inconsistencies between the consent form and the research protocol
The Solution
Draft your informed consent documents with your participants in mind, not your peers. Use language appropriate for an 8th-grade reading level, define all medical terms, and organize information logically. Include all federally required elements as outlined in 45 CFR 46.116 for FDA-regulated research or the Common Rule for federally funded studies.
Before submission, have someone outside your field review the consent form. If they struggle to understand it, so will your participants. Consider using the "teach-back" method during the actual consent process to ensure comprehension.
2. Insufficient Risk Assessment and Mitigation Strategies
The Problem
Many applications fail to thoroughly identify potential risks to participants or lack adequate plans to minimize those risks. This is particularly problematic when:
- The risk-benefit ratio appears unfavorable
- Vulnerable populations are involved without appropriate additional protections
- Researchers downplay or overlook psychological, social, or economic risks
- Monitoring and safety protocols are vague or absent
The Solution
Conduct a comprehensive risk assessment that considers physical, psychological, social, legal, and economic risks. Be honest and thorough—the IRB will appreciate transparency over optimism.
For each identified risk, explain specific mitigation strategies. For example, if your study involves collecting sensitive information, describe your data security measures, encryption protocols, and limited access procedures. If you're working with vulnerable populations such as children, prisoners, or cognitively impaired individuals, include additional safeguards and justify why their inclusion is necessary.
3. Incomplete or Inconsistent Protocols
The Problem
An incomplete protocol leaves too many questions unanswered, while inconsistencies between the protocol, consent forms, and recruitment materials raise red flags. Common issues include:
- Vague descriptions of research procedures
- Missing information about study duration, visit schedules, or participant time commitments
- Contradictory eligibility criteria across documents
- Unclear randomization or blinding procedures
- Inadequate statistical justification for sample size
The Solution
Treat your IRB application as a comprehensive blueprint of your entire study. Every procedure should be clearly described with sufficient detail that an IRB member unfamiliar with your research area can understand what will happen to participants.
Create a checklist to ensure consistency across all documents. If your protocol states participants will have five study visits, this should be reflected identically in the consent form, recruitment materials, and time commitment descriptions. Pay special attention to numerical details—study duration, number of visits, compensation amounts, and sample sizes should match across all documents.
4. Problematic Participant Recruitment and Selection
The Problem
Recruitment strategies and inclusion/exclusion criteria often raise concerns when they:
- Create the appearance of coercion (especially with subordinates or students)
- Unfairly exclude groups without scientific justification
- Use inappropriate incentives that might unduly influence participation
- Target vulnerable populations without adequate justification
- Include discriminatory language or practices
The Solution
Design recruitment strategies that respect participant autonomy and avoid coercion. If recruiting from a population where you have authority (such as your own students or employees), include safeguards to ensure participation is truly voluntary.
Justify all inclusion and exclusion criteria based on scientific necessity rather than convenience. If your study excludes non-English speakers or specific demographic groups, be prepared to explain why this is scientifically necessary.
For compensation, ensure it's proportionate to time and inconvenience without being so high that it becomes coercive. The NIH recommends compensation comparable to minimum wage for time invested.
5. Inadequate Privacy and Confidentiality Protections
The Problem
In our digital age, data protection is paramount. Applications fall short when they:
- Lack specific data security measures
- Fail to explain how identifiable information will be protected
- Don't address data storage, retention, and destruction procedures
- Overlook risks of re-identification in data sharing plans
- Neglect HIPAA compliance when applicable
The Solution
Provide explicit details about how you will protect participant privacy and maintain confidentiality. Specify where data will be stored (physical location and digital platforms), who will have access, how files will be secured (encryption, password protection, locked cabinets), and how long data will be retained.
If you plan to share data with other researchers or repositories, explain how you will de-identify information and assess re-identification risks. For studies involving protected health information, ensure HIPAA compliance and include appropriate authorizations.
6. Missing or Inadequate Supporting Documents
The Problem
IRB applications require numerous supporting documents, and missing or poorly prepared materials can derail approval:
- Outdated investigator CVs or missing training certifications
- Unsigned documents or forms
- Missing letters of support from collaborating institutions
- Inadequate data and safety monitoring plans for high-risk studies
- Lack of study instruments (surveys, interview guides, etc.)
The Solution
Create a comprehensive submission checklist well before your deadline. Ensure all investigators have current human subjects protection training (CITI, NIH, or equivalent) and updated CVs highlighting relevant research experience.
Include all study instruments, even if they're still drafts. Obtain necessary letters of support from department chairs, collaborating institutions, or facilities where research will be conducted. For clinical trials and high-risk studies, develop a detailed data and safety monitoring plan appropriate to the risk level.
7. Failure to Address Regulatory Requirements
The Problem
Different types of research trigger different regulatory requirements, and oversights can lead to rejection:
- Not recognizing when FDA regulations apply (investigational drugs, devices, or biologics)
- Failing to register clinical trials on ClinicalTrials.gov
- Overlooking requirements for IND or IDE applications
- Missing required departmental or institutional approvals
The Solution
Determine early which regulations apply to your research. If you're studying an unapproved drug, device, or biologic, you'll need to address FDA requirements, potentially including an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application.
For clinical trials, plan to register with ClinicalTrials.gov before enrolling participants. Consult with your institution's research office or an experienced IRB to identify all applicable regulations before submitting your application.
Best Practices for IRB Application Success
Start Early
Allow at least 4-6 weeks before you need approval to begin research. Complex studies may require even more time.
Seek Pre-Submission Consultation
Many IRBs offer pre-submission consultations. Take advantage of this opportunity to address potential issues before formal submission.
Use Available Resources
Utilize templates, checklists, and guidance documents provided by your IRB. These resources are designed to help you submit complete, compliant applications.
Assemble a Strong Research Team
Include team members with IRB submission experience. Their insights can help you avoid common pitfalls.
Respond Promptly and Thoroughly
If you receive requests for modifications, respond quickly with comprehensive answers. Don't simply address the surface question—consider the underlying concern and address it fully.
The Cost of Rejection vs. the Value of Preparation
While preparing a thorough IRB application requires significant effort, it's far less costly than dealing with rejections. A rejected or delayed application can:
- Push back research timelines by months
- Jeopardize funding deadlines
- Delay career advancement for students and early-career researchers
- Damage relationships with study sponsors
- Increase overall project costs
Investing time in preparation prevents these cascading consequences and demonstrates your commitment to ethical research practices.
How Elemental IRB Can Help
Navigating the IRB approval process doesn't have to be overwhelming. At Elemental IRB, we specialize in providing efficient, expert ethical oversight for clinical research. Our experienced reviewers understand the common pitfalls that lead to rejections and work collaboratively with researchers to ensure applications meet all regulatory and ethical requirements.
Whether you need full board review, expedited review, or guidance on preparing your application, our team is committed to supporting your research while protecting participant welfare. We offer pre-submission consultations, comprehensive reviews, and responsive communication to keep your research moving forward.
Contact Elemental IRB today to learn how our streamlined review process and expert guidance can help you avoid common rejection pitfalls and get your research approved efficiently.